Cancilico GmbH

At Cancilico, we use artificial intelligence and computer vision to shape the image-based diagnostics of tomorrow. Building upon our multidisciplinary expertise in computer science and clinical medicine, we are dedicated to transforming the way diseases such as hematological cancers are diagnosed and studied. Our mission is to harness the power of AI to substantially improve diagnostics in clinical routine and as part of clinical trials, making it more accurate, efficient, and accessible. Our suite of advanced, user-friendly AI technology can identify relevant mutations and target structures for the development of digital biomarkers. Additionally, we offer our AI capabilities to academic institutions, medical research centers and industry partners and help them drive their research and development forward.